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Nonsyndromic autosomal-recessive optic neuropathies are rare conditions of unknown genetic andmolecular origin. Using an approach
of whole-genome homozygosity mapping and positional cloning, we have identiﬁed the ﬁrst gene, to our knowledge, responsible for
this condition, TMEM126A, in a large multiplex inbred Algerian family and subsequently in three other families originating from the
Maghreb. TMEM126A is conserved in higher eukaryotes and encodes a transmembrane mitochondrial protein of unknown function,
supporting the view that mitochondrial dysfunction may be a hallmark of inherited optic neuropathies including isolated auto-
somal-recessive forms.Hereditary optic atrophy is a group of neurodegenerative
disorders characterized by a sudden or gradual loss of retinal
ganglion cells function. The disease primarily involves the
macular beamof the optic nerve andmayprogress toperiph-
eral ﬁbers. Leber hereditary optic neuropathy (LHON, [MIM
535000]) and autosomal-dominant optic atrophies (adOAs,
[MIM165500])areby farmore frequent thanrecessive forms.
Typically, patients with LHON and adOA have no rele-
vant health problems apart from optic atrophy. However,
the disease may be associated with a wide range of extraoc-
ular features of mitochondrial dysfunction, including
brain, cardiac, muscle, or auditive signs. The clinical
expression of extraocular manifestations varies from
absence of expression to severe dysfunction, which deﬁnes
the ‘‘plus’’ forms of LHON and OPA1.1–4
In contrast with LHON and adOA, autosomal-recessive
optic atrophies (arOAs) usually involve the central nervous
system and other organs. Nonsyndromic arOA are less
common.Hitherto,one locushasbeenmappedbutnodisease
gene has been identiﬁed (OPA6, ROA1 [MIM 258500]).5
Using a combination of Affymetrix GeneChip Human
Mapping 10K 2.0 Arrays and microsatellite markers, we
performed homozygosity mapping in a multiplex inbred
nonsyndromic arOA family of Algerian ancestry. This
approach identiﬁed a unique region of homozygosity on
chromosome 11q14.1-q21 (ROA2, family 1, Figures S1
and S2 available online). The critical interval spanned
14.4 Mb and contained 40 known genes (Figure 1;
maximum LOD score Zmax ¼ 3.73 with no recombination
event at the D11S4187 locus).
Considering that all known optic atrophy genes encode
mitochondrial proteins,6 we selected in the interval three
genes predicted to encode mitochondrial products7
(Figure1).Systematic sequenceanalysis identiﬁedahomozy-gous nonsense mutation in the gene encoding TMEM126A,
a transmembrane protein (c.163C/T; p.Arg55X; GenBank
accession number NM_032273; Figure 1 and Figure S2).
The mutation occurred in a CpG doublet, segregated with
the disease in the family (Figure S2) and was not found in
700 control chromosomes (European, n ¼ 600; Algerian,
n ¼ 100).
We screened 48 additional unrelated patients affected
with nonsyndromic OA (arOA n ¼ 14; adOA n ¼ 10;
sporadic n ¼ 24) for TMEM126A mutations. All affected
patients and their relatives, including all members of
family 1, were recruited with their informed and written
consent, as prescribed by the law on bioethics of the Euro-
pean Community and after approval by the local ethics
committee (DC-2008-512, Paris-Necker). In all cases,
OPA1 mutations and the most frequent LHON mutations
(mtDNA G11778A, G3460A, T14484C, and G15257)
were previously excluded by direct sequencing. None of
the sporadic and adOA cases carried TMEM126A muta-
tions. Conversely, the p.Arg55X mutation was identiﬁed
in three additional arOA families of Maghrebian origin
(Tunisa, family 2; Morocco, Families 3 and 4; Figure S2).
Segregation analysis of microsatellite markers ﬂanking
the mutation supported the hypothesis of a founder effect
by showing the transmission of a small common haplo-
type with the disease in the four families (Figure S2).
Haplotype studies as well as Bayesian calculations8 sug-
gested that the TMEM126A c.163C/T mutation occurred
80 generations ago, i.e., about 2400 years ago (95% cred-
ible interval 35–150 generations).
The p.Arg55X mutation caused an early-onset severe
bilateral deﬁciency in visual acuity (VA), optic disc pallor,
and central scotoma (onset between 4 and 6 years;
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Figure 1. The Critical Region of the ROA2 Locus and the Structure of the TMEM126A Gene and Mutation Identified in Four arOA
Families
(A) Physical map of human chromosome 11q14.1-q21 with selected genetic markers. The location and transcriptional direction of known
genes are schematically represented, and distances are indicated relative to chromosome 11 according to the Ensembl and UCSC Genome
Browser databases. Mitochondrial candidate genes tested in our study are in gray: coiled-coil domain containing (CCDC90B; Maestro
score7 ¼ þ15), transmembrane protein 126A (TMEM126; Maestro score ¼ þ16), and malic enzyme 3 (ME3; Maestro score ¼ þ23).
(B) Structure of the TMEM126A gene and position of the disease-causing mutation identified in arOA families. The gene, located at
11q14.1, covers a genomic region of 8542 bp (GenBank NM_032273) and is composed of five exons. The transcript is 773 bp long,
with coding sequence of 585 bp (exons 2–5, NM_032273.2). The coding region is indicated in gray and UTRs (50 and 30) are in white.
(C) The transmembrane 126A protein is predicted to contain four transmembrane domains (PredictProtein) and a domain of unknown
function DUF1370 (Pfam).
(D) Chromatograms of TMEM126A genomic and cDNA sequences showing a homozygous nonsense c.163C/T; p.Arg55X identified in
patient III6 - family 1.
(E) The arginine at residue 55 is highly conserved in different species (NCBI BLAST).visual ﬁeld was strictly normal in all but the oldest patient,
who lost it between the age of 30 and 37 (III6, family 1;
Figure S3).
The phenotype differs from that of ROA1 patients (OPA6
[MIM 258500]) presenting with an early-onset but slowly
progressive OA affecting the macular beam of optic nerve
with preservation of the peripheral bundles in advanced
stage.5
Polarographic tests and spectrophotometric assays on
cultured skin ﬁbroblasts9 showed normal respiratory chain
function in patient III6 - family 1 but partial deﬁciency of494 The American Journal of Human Genetics 84, 493–498, April 1Complex I in patient V1 - family 2 (17 nmol/min/mg of
protein, mean ¼ 37 5 mean standard deviation 5 nmol/
min/mg of protein). Patient V1 - family 2 presented with
normal brain MRI but moderate hypertrophic cardiomyop-
athy. These features, along with the minor brain MRI alter-
ations (FigureS4) andmildhearing loss inpatient III6 - family
1, are suggestive of a mitochondrial dysfunction as previ-
ouslynoted inpatientswith LHONorOPA1mutations.1–4,10
The TMEM126A gene spans 8.5 kb on chromosome 11
and encodes a single ubiquitous transcript (770 bp) made
of one noncoding and four coding exons (Figure 1).0, 2009
The TMEM126 protein includes the Pfam domain of
unknown function deﬁned by the homology between
the TMEM126A p.Lys5-Gly191 and TMEM126B p.Asn45-
229Glu amino acid sequences, respectively. Four trans-
membrane domains with the N-terminal and C-terminal
sequences on the outside of the membrane were predicted
in the TMEM126A DUF1370 domain (PredictProtein,
Figure 1). Domain of unknown function (DUF) proteins
are hypothetical eukaryotic proteins of around 200 residues
in length. Members of this family are regarded as speciﬁc to
mammals, but phylogenetic analyses contradict this
notion. Indeed, orthologs of several DUF proteins,
includingTMEM126A,havebeen found inmanyvertebrate
and invertebrate species as well as in plant organisms.11,12
No ortholog could be identiﬁed in yeast and fungi.
To determine its subcellular localization, we overex-
pressed a TMEM126A-myc fusion protein into COS-7 cells.
Epitope-tagged wild-type TMEM126A colocalized with
mitochondrial Complex II subunit 70 kDa Fp (SDHA
[MIM 600857]), Complex IV subunit 1 (MTCO1 [MIM
516030]), ATPsynthase subunitbeta (ATP5B [MIM102910]),
and ATP synthase subunit alpha (ATP5A [MIM 164360]),
supporting the mitochondrial localization of the protein
(Figure 2). The fusion protein did not signiﬁcantly colocalize
with the markers of the Golgi apparatus, lysosomes, early
endosomes, cytoskeleton, microtubule, and centrosome
(Figure S5).
RT-PCR on total RNA from various adult and fetal
human tissues showed that TMEM126A is strongly ex-
pressed in the brain (whole), cerebellum, fetal brain, skel-
etal muscle, testis, fetal retinal pigmentary epithelium
(RPE), and fetal retina (Figure S6). In situ hybridization
on adult mouse retina (8 months) detected signiﬁcant
levels of speciﬁc mRNA in the ganglion cell layer (GCL),
the optic nerve head (ON), the outer plexiform layer
(OPL), and in the outer ellipsoide (oe) length of photore-
ceptor inner segments (IS). Faint to no labeling was noted
in the outer nuclear layer (ONL) and photoreceptor outer
segments. Immunolocalization of the mitochondria-
speciﬁc alpha subunit of the ATP synthase (ATP5A) on
retinal sections of the same animal showed the same
pattern of expression, supporting the view that
TMEM126A transcripts colocalized with mitochondria
(Figure 3). This result suggests that similarly to the dyna-
min-related GTPase protein Mgm1, of which OPA1 is the
human ortholog, TMEM126A is a mitochondria-localized
mRNA (MLR) proteins and may be essential in the early
nucleation process of large mitochondrial complexes.13–16
In contrast to OPA1mutations, we found no fragmenta-
tion of the mitochondrial network and/or in depletions of
the mitochondrial DNA (mtDNA)17,18 in the ﬁbroblasts of
patients III6 - family 1 and V1 - family 2 (data not shown),
suggesting that TMEM126A and OPA1 may not be func-
tionally related.
Recently, mutations in another TMEM protein have
been reported to cause neonatal mitochondrial encephalo-
cardiomyopathy.12 Interestingly, the absence of TMEM70The Amein patients resulted in the loss of ATP synthase,12 whose
subunits have also been shown to be MLR proteins.16
As a probable MLR protein, TMEM126A may be impor-
tant to the assembly of a protein complex required for
the function of retinal ganglion cells in higher eukaryotes.
In other tissues, it is possible that another protein of the
TMEM family could adequately substitute for the defective
function of TMEM126A. It is also possible that TMEM126A
may be required to accelerate the assembly of a protein
complex. In the absence of TMEM126A, the complex
would constitute slowly, and only high-energy-demanding
retinal ganglion cells would be affected.
We have identiﬁed TMEM126A as a gene that encodes
a mitochondrial protein of higher eukaryotes and whose
mutations are to our knowledge the ﬁrst known genetic
cause of nonsyndromic autosomal-recessive optic atrophy.
This ﬁnding gives further support to the view that mito-
chondrial dysfunctions are a hallmark of optic neuropa-
thies, suggesting that common therapeutic approaches
may be developed to improve the long-term prognosis of
patients whatever the gene involved.19,20
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Figure 2. Localization of Transmembrane 126A Protein to Mitochondria of Cultured Cells
Expression in COS-7 cells of a TMEM126-myc fusion protein labeled 48 hr after transfection with an antibody against the myc tag (green)
compared to mitochondrial markers (red) via the following primary antibodies: mouse monoclonal anti-Complex II subunit 70 kDa Fp
(1/2000, MitoSciences) for succinate dehydrogenase complex, subunit A, flavoprotein (Fp); mouse monoclonal anti-Complex IV subunit
1 (1/200, MitoSciences) for mitochondrially encoded cytochrome c oxidase I; mouse monoclonal anti-ATP synthase subunit beta (1/400,
MitoSciences) for ATP synthase, Hþ transporting, mitochondrial F1 complex, beta polypeptide; and mouse monoclonal anti-ATP synthase
subunit alpha (1/500, MitoSciences) for ATP synthase, Hþ transporting, mitochondrial F1 complex, alpha subunit 1. The Pearson’s coef-
ficient (r) was calculated with the ImageJ 1.42d software to estimate the degree of colocalization between TMEM126-myc and organelle
markers. Its value can range from 1 to 1, with 1 standing for complete positive correlation and 1 for a negative correlation, and with
zero standing for no correlation. Pearson’s coefficients between TMEM126-myc and mitochondria markers are > 0.83, showing a strong
colocalization. These results were confirmed by JACoP Van Steenel’s CCF coefficients21 and Pearson’s coefficients calculated with Imaris
6.1.5 software (data not shown). Images were acquired with a Leica SP5 confocal microscope (objective 633; scale bar represents 20 mm)
and Leica Application Suite Advanced Fluorescence Lite software.
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Figure 3. Analysis of TMEM126 mRNA Expression by In Situ Hybridization Compared to Localization of Mitochondria in Adult
Mouse Retina
Murine retina cDNA was amplified with primers 50-T7-ACAGAGTCACGTGTGAGCCAA-30 and 50-CCATTGACGGGTATAGCCAA-30 (sense probe) and
50-T7-CCATTGACGGGTATAGCCAA-30 and 50-ACAGAGTCACGTGTGAGCCAA-30 (antisense probe) to produce a 524 bp product of the mouse
Tmem126a coding region (NM_025460, primer T7: 50-TAATACGACTCACTATAGGGAGA-30). The PCR products were purified (QIAquick PCR
Purification Kit), verified by sequencing, and subsequently amplified by PCR with T7-polymerase-specific primers (Invitrogen) and Digox-
igenin (DIG) RNA labeling mix (Roche). The DIG-labeled cRNA probes were hybridized to the mouse retina sections and detected with an
anti-digoxygenin alkaline phosphatase-linked antibody (Roche) and visualized with NBT/BCIP (Roche).
(A–L) Magnification of the mouse retinal cell layers.
(D–L) In adult mouse retina, TMEM126 gene is expressed in the ganglion cell layer (GCL), the inner nuclear layer (INL), the outer plexiform
layer (OPL), and the outer ellipsoide (oe) length of photoreceptors inner segments (IS). The staining is slightly less pronounced in the
optic nerve (ON) and in the inner plexiform layer. TMEM126A mRNA was not detected in the outer nuclear layer (ONL), outer plexiform
layer, or the inner plexiform layer.
(G–I) A sense DIG-cRNA probe revealed no staining in all cellular layers indicating the specificity of the assay. (J and K) Immunolocal-
ization of mitochondria in mouse retinal cell layers with an anti-ATP5A. Mitochondria are sequestered in the ganglion cell layer, the outer
plexiform layer, the outer ellipsoid length of the photoreceptors’ inner segments, the retinal pigment epithelium cells, and the optic
nerve.
(L) Negative control. Note that outer segments display an autofluorescence. PCL denotes photoreceptor cell layer, OS denotes outer
segments, and RPE denotes retinal pigment epithelium. Images were recorded on an Olympus IX81 microscope (objective 103 and
403; scale bar represents 100 mm) with an Olympus DP70 camera, processed with Soft Imaging System CellˆP and Leica SP5 confocal
microscope (objective 403 oil-immersion objective; scale bar represents 50 mm) and Leica Application Suite Advanced Fluorescence
Lite software for immunohistochemistry.References
1. Lev, D., Yanoov-Sharav, M., Watemberg, N., Leshinsky-Silver,
E., and Lerman-Sagie, T. (2002). White matter abnormalities
in Leber’s hereditary optic neuropathy due to the 3460 mito-
chondrial DNA mutation. Eur. J. Paediatr. Neurol. 6, 121–123.
2. Vinkler, C., Lev, D., Kalish, H., Watemberg, N., Yanoov-Sharav,
M., Leshinsky-Silver, E., and Lerman-Sagie, T. (2003). Familial
optic atrophy with white matter changes. Am. J. Med. Genet.
A. 121A, 263–265.The Am3. Yu-Wai-Man, P., Grifﬁths, P.G., Hudson, G., and Chinnery, P.F.
(2009). Inherited Mitochondrial Optic Neuropathies. J. Med.
Genet. 46, 145–158.
4. Amati-Bonneau, P., Valentino, M.L., Reynier, P., Gallardo,
M.E., Bornstein, B., Boissie`re, A., Campos, Y., Rivera, H., de
la Aleja, J.G., Carroccia, R., et al. (2008). OPA1 mutations
induce mitochondrial DNA instability and optic atrophy
‘plus’ phenotypes. Brain 131, 338–351.
5. Barbet, F., Gerber, S., Hakiki, S., Perrault, I., Hanein, S., Ducroq,
D., Tanguy, G., Duﬁer, J.L., Munnich, A., Rozet, J.M., et al.erican Journal of Human Genetics 84, 493–498, April 10, 2009 497
(2003). A ﬁrst locus for isolated autosomal recessive optic
atrophy (ROA1) maps to chromosome 8q. Eur. J. Hum. Genet.
11, 966–971.
6. Carelli,V., LaMorgia,C., Iommarini, L.,Carroccia,R.,Mattiazzi,
M., Sangiorgi, S., Farne, S., Maresca, A., Foscarini, B., Lanzi, L.,
et al. (2007). Mitochondrial optic neuropathies: How two
genomes may kill the same cell type? Biosci. Rep. 27, 173–184.
7. Calvo, S., Jain, M., Xie, X., Sheth, S.A., Chang, B., Goldberger,
O.A., Spinazzola, A., Zeviani, M., Carr, S.A., and Mootha, V.K.
(2006). Systematic identiﬁcation of human mitochondrial
disease genes through integrative genomics. Nat. Genet. 38,
576–582.
8. Hanein, S., Perrault, I., Gerber, S., Delphin, N., Benezra, D.,
Shalev, S., Carmi, R., Feingold, J., Duﬁer, J.L., Munnich, A.,
et al. (2008). Population history and infrequent mutations:
How old is a rare mutation? GUCY2D as a worked example.
Eur. J. Hum. Genet. 16, 115–123.
9. Rustin, P., Chretien, D., Bourgeron, T., Ge´rard, B., Ro¨tig, A.,
Saudubray, J.M., and Munnich, A. (1994). Biochemical and
molecular investigations in respiratory chain deﬁciencies.
Clin. Chim. Acta 228, 35–51.
10. Zanna, C., Ghelli, A., Porcelli, A.M., Karbowski, M., Youle, R.J.,
Schimpf, S., Wissinger, B., Pinti, M., Cossarizza, A., Vidoni, S.,
et al. (2008). OPA1 mutations associated with dominant optic
atrophy impair oxidative phosphorylation andmitochondrial
fusion. Brain 131, 352–367.
11. Smith, U.M., Consugar, M., Tee, L.J., McKee, B.M., Maina,
E.N., Whelan, S., Morgan, N.V., Goranson, E., Gissen, P., Lilli-
quist, S., et al. (2006). The transmembrane protein meckelin
(MKS3) is mutated in Meckel-Gruber syndrome and the wpk
rat. Nat. Genet. 38, 191–196.
12. Cizkova, A., Stra´necky´, V., Mayr, J.A., Tesarova´, M., Havlı´ck-
ova´, V., Paul, J., Iva´nek, R., Kuss, A.W., Hansı´kova´, H., Kapla-
nova´, V., et al. (2008). TMEM70 mutations cause isolated
ATP synthase deﬁciency and neonatal mitochondrial ence-
phalocardiomyopathy. Nat. Genet. 40, 1288–1290.
13. Heinrich, P.C., Schmelzer, E., Northemann,W., Kaiser, C., and
Witt, I. (1982). Rat liver cytochrome c oxidase subunits IV and498 The American Journal of Human Genetics 84, 493–498, April 10V: Cell-free synthesis as larger molecular weight precursors,
mRNA sizes and sites of synthesis. Prog. Clin. Biol. Res. 102,
149–159.
14. Rings, E.H., Bu¨ller, H.A., de Boer, P.A., Grand, R.J., Montgom-
ery, R.K., Lamers, W.H., Charles, R., and Moorman, A.F.
(1992). Messenger RNA sorting in enterocytes. Co-localization
with encoded proteins. FEBS Lett. 300, 183–187.
15. Sylvestre, J., Vialette, S., Corral Debrinski, M., and Jacq, C.
(2003). Long mRNAs coding for yeast mitochondrial proteins
of prokaryotic origin preferentially localize to the vicinity of
mitochondria. Genome Biol. 4, R44.
16. Garcia, M., Darzacq, X., Delaveau, T., Jourdren, L., Singer,
R.H., and Jacq, C. (2007). Mitochondria-associated yeast
mRNAs and the biogenesis of molecular complexes. Mol.
Biol. Cell 18, 362–368.
17. Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Bez-
noussenko, G.V., Rudka, T., Bartoli, D., Polishuck, R.S., Danial,
N.N., De Strooper, B., and Scorrano, L. (2006). OPA1 controls
apoptotic cristae remodeling independently from mitochon-
drial fusion. Cell 126, 177–189.
18. Olichon, A., Landes, T., Arnaune´-Pelloquin, L., Emorine, L.J.,
Mils, V., Guichet, A., Delettre, C., Hamel, C., Amati-Bonneau,
P., Bonneau, D., et al. (2007). Effects of OPA1 mutations on
mitochondrial morphology and apoptosis: Relevance to
ADOA pathogenesis. J. Cell. Physiol. 211, 423–430.
19. Delettre, C., Lenaers, G., Griffoin, J.M., Gigarel, N., Lorenzo,
C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C.,
Perret, E., et al. (2000). Nuclear gene OPA1, encoding a mito-
chondrial dynamin-related protein, is mutated in dominant
optic atrophy. Nat. Genet. 26, 207–210.
20. Chevrollier, A., Guillet, V., Loiseau, D., Gueguen, N., de Cre-
scenzo, M.A., Verny, C., Ferre, M., Dollfus, H., Odent, S.,
Milea, D., et al. (2008). Hereditary optic neuropathies share
a common mitochondrial coupling defect. Ann. Neurol. 63,
794–798.
21. Bolte, S., and Cordelie`res, F.P. (2006). A guided tour into
subcellular colocalization analysis in light microscopy. J.
Microsc. 224, 213–232., 2009
